If you liked alcohol-free beer, you'll just love this:
A British drug manufacturer is hoping for a big score from consumers and a green light from the FDA for its medical marijuana mouth spray in 2013.
Seven countries including the UK, Spain and Germany have approved Sativex to treat patients with multiple sclerosis. Makers GW Pharmaceuticals hopes the drug will be used as a prescribed replacement to medical marijuana in the United States.
Patients take the drug by spraying it into their mouths like a breath spray with a dosage meter. This way, GW Pharmaceuticals says people can derive maximum benefit from the drug without feeling a “high.”
I hate to tell medical marijuana fans this, but "feeling a high" is the major part of the "maximum benefit."
